Lupin Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2025.

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹2082.00

prior close

₹2100.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.7%-1.3% vs market

Pharmaceuticals peers, median of 150sector+0.4%-1.0% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Midcap 150 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.7

15m

-0.9

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.7-1.3+0.4-1.0

Next day

-0.8+1.6-2.4+0.9-1.7

-2.6+1.7-4.3+2.0-4.5

-5.4+0.1-5.5+1.2-6.6

-4.4+0.9-5.3+1.9-6.3

-5.5+0.6-6.0+2.0-7.5

-4.5+1.7-6.2+1.7-6.2

15d

-4.2+4.1-8.2+2.8-6.9

-3.3+4.6-7.9+2.9-6.2

-6.0+6.5-12.5+4.8-10.9

-5.3+3.0-8.3+0.2-5.4

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lupin reported strong FY25 results with standalone revenue growing ~15.7% YoY to ₹16,968 crore and net profit surging ~71% to ₹3,973 crore. Q4 standalone revenue rose ~32% to ₹4,486 crore with net profit of ₹1,291 crore (vs ₹384 crore in Q4 FY24). On a consolidated basis, FY25 revenue grew ~13.5% to ₹22,708 crore while PAT jumped ~71% to ₹3,306 crore. Standalone EPS for the year stood at ₹87.10 versus ₹51.10 last year. The Board recommended a dividend of ₹12 per share (600% on face value of ₹2), aggregating to ₹547.9 crore, subject to shareholder approval. The company recorded exceptional items of ₹77.2 crore towards impairment of investments in two subsidiaries and made a ₹85.6 crore provision for an ongoing dispute. Auditors B S R & Co. LLP issued an unmodified opinion on the results.

Likely market impact

Strong double-digit profit growth, expanding margins, and a healthy 600% dividend make this a positive outcome for shareholders. The robust earnings may support positive sentiment, though the new debt raise and provisions for disputes are minor watchpoints.